New HIV pregnancy study uses latest ART: IMPAACT 2010 study (VESTED) includes dolutegravir and tenofovir alafenamide (TAF)
9 February 2018. Related: Pregnancy.
Pregnancy
Association between timing of maternal ART and risk of infants born small for gestational age in Dutch ATHENA cohort
9 February 2018. Related: Pregnancy.
Dolutegravir use in pregnancy: results from small Belgian cohort
28 November 2017. Related: Conference reports, Pregnancy.
No transmissions from breastfeeding in Tanzania cohort from mothers with undetectable viral load
28 November 2017. Related: Conference reports, Pregnancy.
Reassuring French data using raltegravir during pregnancy
28 November 2017. Related: Conference reports, Pregnancy.
Screening HIV positive pregnant women for TB in South Africa increased detection by 10-fold
28 November 2017. Related: Conference reports, Women's health, Pregnancy, HIV prevention and transmission.
Experts disagree with controversial BMJ support for older HIV drugs in pregnancy
1 October 2017. Related: Special reports, Women's health, Pregnancy.
BHIVA challenges BMJ recommendations on ART during pregnancy: tenofovir still strongly recommend
1 October 2017. Related: Pregnancy.
Preliminary results on dolutegravir use in pregnancy are reassuring
10 August 2017. Related: Conference reports, Pregnancy.
Low dose efavirenz (EFV400) can be used during pregnancy
10 August 2017. Related: Conference reports, Pregnancy.
Stillbirth rate in HIV positive women in UK/Ireland is double that of the general population
10 August 2017. Related: Conference reports, Pregnancy.
Inconsistencies between real-world data from UK and Ireland and EU recommendations for new antiretrovirals in pregnancy
10 August 2017. Related: Conference reports, Pregnancy.
Dolutegravir pharmacokinetics in pregnancy
26 June 2017. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Option B+ Malawi
26 June 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
VRC01 in HIV-exposed newborns: first results support monthly injections for those at risk through breastfeeding
24 April 2017. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
PrEP in pregnancy does not increase poor birth outcomes
24 April 2017. Related: Conference reports, Pregnancy, HIV prevention and transmission.
Efavirenz, tenofovir and emtricitabine associated with fewest adverse birth outcomes in Botswana
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
Adverse pregnancy outcomes and risk factors in the PROMISE trial
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
Women on lopinavir/ritonavir-based regimens at conception at higher risk of preterm delivery in UK study
27 February 2017. Related: Conference reports, Antiretrovirals, Pregnancy.
No increase in adverse birth outcomes with maternal TDF/FTC in US study
27 February 2017. Related: Conference reports, Pregnancy.
Pregnancy common in ART trials in sub-Saharan Africa despite exclusion criteria
27 February 2017. Related: Pregnancy.
TDF/FTC can be used as PrEP by breastfeeding mothers without risk to the baby
29 November 2016. Related: Conference reports, Pregnancy, HIV prevention and transmission.
Dolutegravir use in a London cohort – including nine pregnant women
29 November 2016. Related: Pregnancy.
HIV positive and HIV negative pregnancies in the UK and Ireland have similar outcomes including for older women: impressive 15-year review
29 November 2016. Related: Pregnancy.
High risk of virological failure and loss to follow up postpartum in South Africa
1 October 2016. Related: Conference reports, Pregnancy.
Birth weight and preterm delivery outcomes of vertically vs non-vertically infected HIV positive pregnant women
1 October 2016. Related: Conference reports, Pregnancy.
High death rates among HIV positive women postpartum accessing ARVs
1 October 2016. Related: Conference reports, Antiretrovirals, Pregnancy.
Raltegravir in HIV-exposed neonates
1 October 2016. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Tenofovir-containing ART reduces bone mineral density in breast feeding women: results from IMPAACT P1084s
1 October 2016. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
Dolutegravir is superior to boosted atazanavir in women in the ARIA study
1 August 2016. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
PROMISE results support WHO recommendations for pregnant and breastfeeding women: more needs to be done to improve ART acceptability and adherence
1 August 2016. Related: Conference reports, Pregnancy, Paediatric care, HIV prevention and transmission.
Modelling data might support use of low dose 400 mg efavirenz in pregnancy
1 August 2016. Related: Conference reports, Pregnancy.
Pharmacokinetics of antiretrovirals comparable to that in non-pregnant women from three weeks after delivery
1 August 2016. Related: Conference reports, Antiretrovirals, Pregnancy.
No effect of tenofovir on infant bone mineral content in African study
1 June 2016. Related: Conference reports, Antiretrovirals, Pregnancy, Paediatric care.
No increased risk of birth defects with darunavir: findings from the Antiretroviral Pregnancy Registry
1 June 2016. Related: Conference reports, Pregnancy.
Early data from dolutegravir use during pregnancy
22 March 2016. Related: Conference reports, Pregnancy.
Raltegravir for neonates will require a complicated dosing regimen
1 October 2015. Related: Conference reports, Pregnancy, Paediatric care.
Reducing efavirenz dose is unlikely to overcome interaction with levonorgestrel
1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.
Pharmacokinetics of four antiretrovirals in pregnancy: data from the PANNA network
1 October 2015. Related: Conference reports, Pregnancy, PK and drug interactions.
Dolutegravir placental transfer moderate in ex vivo model
1 October 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
BHIVA pregnancy audit 2013 to 2014
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy.
Transmitted drug resistance in HIV positive pregnant women
1 June 2015. Related: Conference reports, Pregnancy, Drug resistance.
PK of ARVs in pregnancy: rilpivirine, etravirine and raltegravir
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Pharmacokinetics in pregnancy: darunavir/r and etravirine
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Low prolactin and high 20alpha-HSD might contribute to ART-associated progesterone deficits in pregnancy
1 June 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Pregnancy rates among women using ART and hormonal contraceptives in Kenya
1 June 2015. Related: Conference reports, Antiretrovirals, Pregnancy.
Adolescents at increased risk of vertical transmission and poor pregnancy outcome in South Africa
1 June 2015. Related: Conference reports, Women's health, Pregnancy.
Three drug ART best for preventing vertical transmission to infants: results from the PROMISE study
24 March 2015. Related: Conference reports, Pregnancy.
3 in 5 breastfeeding women with viral load >1,000 copies/mL are undiagnosed in Kenya, Malawi and South Africa
24 March 2015. Related: Conference reports, Pregnancy.
Point of care HIV PCR test for infant diagnosis: good performance but poorer results in youngest age group
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Diagnostics.
Drug resistance in children after PMTCT and early treatment
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Drug resistance.
Three drug regimen superior for preventing vertical transmission in the PROMISE study
29 January 2015. Related: Pregnancy.
Increased risk of ART-related hepatotoxicity in HIV positive pregnant women
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
Darunavir pharmacokinetics in pregnancy and postpartum
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Good management of HIV positive pregnant women in UK – with some room for improvement
1 December 2014. Related: Conference reports, Pregnancy.
Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents
1 December 2014. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
Reasons for loss to follow up in the Malawi Option B+ programme
1 October 2014. Related: Conference reports, Pregnancy.
BHIVA pregnancy guidelines: 2014 interim update
1 October 2014. Related: Pregnancy, Guidelines.
Raltegravir pharmacokinetics in pregnancy and neonates
1 October 2014. Related: Pregnancy.
Efavirenz pharmacokinetics among pregnant women with and without tuberculosis coinfection
1 October 2014. Related: Pregnancy, TB coinfection.
Pregnancy outcomes in Zambia
1 August 2014. Related: Conference reports, Pregnancy.
Uptake of ART is influenced by distance to the health facility in rural Zambia
1 August 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Pharmacokinetics of antiretrovirals in pregnancy
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
HIV related infections remain the leading cause of maternal deaths in South Africa despite the availability of ART
24 March 2014. Related: Conference reports, Pregnancy.